Skip to main content
. 2021 Apr 26;11:8963. doi: 10.1038/s41598-021-88355-9

Figure 6.

Figure 6

I194496 inhibits the Anxa2/STAT3 and VEGF/FAK/Paxillin signalling pathways in human TNBC cells. (A, B) The effect of I194496 on Anxa2/STAT3 pathway in MDA-MB-231 cells. *P < 0.05 vs 0 μM I194496 group. P < 0.05 vs 20 μM I194496 group. ΔP < 0.05 vs 30 μM I194496 group. (C, D) The effect of I194496 on Anxa2/STAT3 pathway in MDA-MB-468 cells. *P < 0.05 vs 0 μM I194496 group. P < 0.05 vs 24 μM I194496 group. ΔP < 0.05 vs 28 μM I194496 group. (E, F) The effect of I194496 on VEGF/FAK/Paxillin signaling pathway in MDA-MB-231 cells. *P < 0.05 vs 0 μM I194496 group. P < 0.05 vs 20 μM I194496 group. ΔP < 0.05 vs 30 μM I194496 group. (G, H) The effect of I194496 on VEGF/FAK/Paxillin signaling pathway in MDA-MB-468 cells. *P < 0.05 vs 0 μM I194496 group. P < 0.05 vs 24 μM I194496 group. ΔP < 0.05 vs 28 μM I194496 group.